Literature DB >> 26305594

Myostatin: expanding horizons.

Mridula Sharma1,2, Craig McFarlane2, Ravi Kambadur2,3, Himani Kukreti1, Sabeera Bonala2, Shruti Srinivasan1.   

Abstract

Myostatin is a secreted growth and differentiation factor that belongs to the TGF-β superfamily. Myostatin is predominantly synthesized and expressed in skeletal muscle and thus exerts a huge impact on muscle growth and function. In keeping with its negative role in myogenesis, myostatin expression is tightly regulated at several levels including epigenetic, transcriptional, post-transcriptional, and post-translational. New revelations regarding myostatin regulation also offer mechanisms that could be exploited for developing myostatin antagonists. Increasingly, it is becoming clearer that besides its conventional role in muscle, myostatin plays a critical role in metabolism. Hence, molecular mechanisms by which myostatin regulates several key metabolic processes need to be further explored.
© 2015 International Union of Biochemistry and Molecular Biology.

Entities:  

Keywords:  cancer cachexia; insulin resistance; muscle wasting; myostatin; sarcopenia; skeletal muscle

Mesh:

Substances:

Year:  2015        PMID: 26305594     DOI: 10.1002/iub.1392

Source DB:  PubMed          Journal:  IUBMB Life        ISSN: 1521-6543            Impact factor:   3.885


  25 in total

1.  Effect of Testosterone on FGF2, MRF4, and Myostatin in Hypogonadotropic Hypogonadism: Relevance to Muscle Growth.

Authors:  Husam Ghanim; Sandeep Dhindsa; Manav Batra; Kelly Green; Sanaa Abuaysheh; Nitesh D Kuhadiya; Antoine Makdissi; Ajay Chaudhuri; Paresh Dandona
Journal:  J Clin Endocrinol Metab       Date:  2019-06-01       Impact factor: 5.958

Review 2.  Characterizing skeletal muscle dysfunction in women with polycystic ovary syndrome.

Authors:  Tara McDonnell; Leanne Cussen; Marie McIlroy; Michael W O'Reilly
Journal:  Ther Adv Endocrinol Metab       Date:  2022-07-18       Impact factor: 4.435

3.  Genetic Control of Lyme Arthritis by Borrelia burgdorferi Arthritis-Associated Locus 1 Is Dependent on Localized Differential Production of IFN-β and Requires Upregulation of Myostatin.

Authors:  Jackie K Paquette; Ying Ma; Colleen Fisher; Jinze Li; Sang Beum Lee; James F Zachary; Yong Soo Kim; Cory Teuscher; Janis J Weis
Journal:  J Immunol       Date:  2017-10-06       Impact factor: 5.422

4.  Postnatal development of skeletal muscle in pigs with intrauterine growth restriction: morphofunctional phenotype and molecular mechanisms.

Authors:  Fernando Felicioni; Andreia D Pereira; Andre L Caldeira-Brant; Thais G Santos; Thais M D Paula; Diogo Magnabosco; Fernando P Bortolozzo; Stephen Tsoi; Michael K Dyck; Walter Dixon; Patricia M Martinelli; Erika C Jorge; Helio Chiarini-Garcia; Fernanda R C L Almeida
Journal:  J Anat       Date:  2020-01-29       Impact factor: 2.610

Review 5.  Comparative Skeletal Muscle Proteomics Using Two-Dimensional Gel Electrophoresis.

Authors:  Sandra Murphy; Paul Dowling; Kay Ohlendieck
Journal:  Proteomes       Date:  2016-09-09

6.  Elevated serum myostatin level is associated with worse survival in patients with liver cirrhosis.

Authors:  Hiroki Nishikawa; Hirayuki Enomoto; Akio Ishii; Yoshinori Iwata; Yuho Miyamoto; Noriko Ishii; Yukihisa Yuri; Kunihiro Hasegawa; Chikage Nakano; Takashi Nishimura; Kazunori Yoh; Nobuhiro Aizawa; Yoshiyuki Sakai; Naoto Ikeda; Tomoyuki Takashima; Ryo Takata; Hiroko Iijima; Shuhei Nishiguchi
Journal:  J Cachexia Sarcopenia Muscle       Date:  2017-06-18       Impact factor: 12.910

7.  Myostatin and beyond in cirrhosis: all roads lead to sarcopenia.

Authors:  Srinivasan Dasarathy
Journal:  J Cachexia Sarcopenia Muscle       Date:  2017-12       Impact factor: 12.910

Review 8.  Candidate rejuvenating factor GDF11 and tissue fibrosis: friend or foe?

Authors:  Jan Frohlich; Manlio Vinciguerra
Journal:  Geroscience       Date:  2020-10-06       Impact factor: 7.713

9.  The relationship between changes in serum myostatin and adiponectin levels in patients with obesity undergoing a weight loss program.

Authors:  Nana Takao; Satoshi Kurose; Takumi Miyauchi; Katsuko Onishi; Atsuko Tamanoi; Ryota Tsuyuguchi; Aya Fujii; Sawako Yoshiuchi; Kazuhisa Takahashi; Hiromi Tsutsumi; Yutaka Kimura
Journal:  BMC Endocr Disord       Date:  2021-07-08       Impact factor: 2.763

Review 10.  Combined Therapies for Duchenne Muscular Dystrophy to Optimize Treatment Efficacy.

Authors:  Gonzalo Cordova; Elisa Negroni; Claudio Cabello-Verrugio; Vincent Mouly; Capucine Trollet
Journal:  Front Genet       Date:  2018-04-10       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.